The Aperlena Verdict
Open raceNo supplier dominates: 25 different companies have won the last 31 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -10.5%
- Expected final price vs the published estimate
Based on 31 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe buyer, University Hospital Pilsen (FN Plzen), is procuring supplies of medicinal products for the treatment of hormone-sensitive prostate cancer. The procurement covers two oral forms containing apalutamide: 60 mg units with an estimated annual volume of 62,400 doses and 240 mg units with an estimated annual volume of 57,600 doses, with a total expected volume of 360,000 individual doses. Deliveries will run for three years from signing of the purchase contract, following a completed tender procedure, and will serve healthcare facilities of FN Plzen. ATC code L02BB05.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago
More from this buyer
Full buyer profile8 open tenders right now
- Czech Republic - Diagnostic ultrasound devices - Supply of sonography equipment - UROL - 2026 5 days left
- Czech Republic - Paper hand towels - Supply of disposable paper hygiene products 2026 13 days left
- Czech Republic - Paper hand towels - Supply of disposable paper hygiene products 2026 22 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| KLARO, spol. s r.o. | 3 | €29,131 | May 2026 |
| Bristol-Myers Squibb spol. s r.o. | 2 | €16.8M | Nov 2025 |
| Gilead Sciences s.r.o. | 2 | €11.3M | Jan 2026 |
| Olympus Czech Group, s.r.o., člen koncernu; MEDISERVIS s.r.o. | 2 | €561,567 | Apr 2026 |
| Medline International CZ s.r.o.; HARTMANN - RICO a.s. | 2 | €315,086 | Mar 2026 |
Based on 31 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 30 comparable contracts this buyer awarded in this sector over the last 4 years.
- €179,474
- Lower quartile
- €2.8M
- Median award
- €6.9M
- Upper quartile
This tender is estimated 262.3% above that median
Most recent awards
- Czech Republic - Antineoplastics and immunomodulators - medicinal product for autologous cell therapy - ciltakabtagene autoleucel - 2026 €12,264,775
- Česko - Léčivé přípravky a zdravotnické prostředky - Infuzní a oplachové roztoky 2026 €2,510,173
- Antineoplastics and immunomodulators - Antineoplastics and immunomodulators 2026-II €9,638,262
- Česko - Antineoplastika a imunomodulátory - Antineoplastika a imunomodulátory 2026-II €9,607,386
- Česko - Lékařský nábytek - Zavedení DNS pro opakované nákupy nábytku z nerezu €18,341
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€414,027
est. value
1
day left
€288,329
est. value
1
day left
€5,769,865
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,028,743
- Buyer track record on Aperlena
- 117 notices tracked · 65 awarded
- €272,922,966 in awarded contracts
Never miss a tender like this
171 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert